These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 18451095)
1. A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action. Paulmurugan R; Tamrazi A; Katzenellenbogen JA; Katzenellenbogen BS; Gambhir SS Mol Endocrinol; 2008 Jul; 22(7):1552-64. PubMed ID: 18451095 [TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary. Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904 [TBL] [Abstract][Full Text] [Related]
3. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha. Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588 [TBL] [Abstract][Full Text] [Related]
4. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986 [TBL] [Abstract][Full Text] [Related]
5. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652 [TBL] [Abstract][Full Text] [Related]
7. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164 [TBL] [Abstract][Full Text] [Related]
8. An Hsp27-related, dominant-negative-acting intracellular estradiol-binding protein. Chen H; Hewison M; Hu B; Sharma M; Sun Z; Adams JS J Biol Chem; 2004 Jul; 279(29):29944-51. PubMed ID: 15123601 [TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. Reese JC; Katzenellenbogen BS J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605 [TBL] [Abstract][Full Text] [Related]
11. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936 [TBL] [Abstract][Full Text] [Related]
13. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213 [TBL] [Abstract][Full Text] [Related]
14. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Cheng J; Zhang C; Shapiro DJ Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152 [TBL] [Abstract][Full Text] [Related]
15. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597 [TBL] [Abstract][Full Text] [Related]
16. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation. Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255 [TBL] [Abstract][Full Text] [Related]
17. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206 [TBL] [Abstract][Full Text] [Related]
18. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12. Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361 [TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493 [TBL] [Abstract][Full Text] [Related]
20. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]